EBITDA Margin % is calculated as EBITDA divided by its Revenue. Beamtree Holdings's EBITDA for the
six
months ended in Dec. 2025 was A$-0.44 Mil. Beamtree Holdings's Revenue for the
six
months ended in Dec. 2025 was A$14.53 Mil. Therefore, Beamtree Holdings's EBITDA margin for the quarter that ended in Dec. 2025 was -3.06%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Beamtree Holdings EBITDA Margin % Related Terms
Beamtree Holdings EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Beamtree Holdings's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:BMT vs VEEV, BTSG, TEM: EBITDA Margin % Comparison
For the Health Information Services subindustry, Beamtree Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beamtree Holdings EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Beamtree Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Beamtree Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beamtree Holdings (ASX:BMT) has a EBITDA Margin % of -3.06% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Beamtree Holdings and its competitors. According to the industry distribution chart, Beamtree Holdings ranks #513 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 76.8%.
Is Beamtree Holdings' EBITDA Margin % too high?
Beamtree Holdings' current EBITDA Margin % is -3.06%. Based on the distribution chart, Beamtree Holdings ranks #513 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Beamtree Holdings has a GF Score™ of 28/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Beamtree Holdings' EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Beamtree Holdings ranks #513 out of 668 companies for EBITDA Margin %. This places Beamtree Holdings in the lower half of its industry. The industry median EBITDA Margin % is 10.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Beamtree Holdings and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beamtree Holdings's current EBITDA Margin % is -3.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beamtree Holdings stock overvalued right now?
Based on GuruFocus' analysis, Beamtree Holdings (ASX:BMT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.54, compared to a current price of A$0.16 — trading 71.3% below its estimated fair value. The current EBITDA Margin % is -3.06%. Beamtree Holdings' overall GF Score™ is 28/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Beamtree Holdings (ASX:BMT), the current EBITDA Margin % is -3.06% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beamtree Holdings (ASX:BMT) Overvalued in 2026?
Based on GuruFocus' analysis, Beamtree Holdings stock appears to be undervalued.
The current stock price of A$0.16 is trading 71.3% below its estimated GF Value™ of A$0.54.
GuruFocus considers Beamtree Holdings to be Possible Value Trap.
Key valuation signals for ASX:BMT:
EBITDA Margin %: -3.06%
GF Value™: A$0.54 vs. price of A$0.16 (71.3% below fair value)
No single metric tells the full story. See the ASX:BMT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beamtree Holdings Ltd is an Artificial intelligence (AI) health technology company. It offers software solutions like Picq, RippleDown, Risq, Ainsoff, Q Coding platform, and others across four product segments that combine into a modular software suite to assist healthcare services in transforming the quality of their data, analyzing key performance insights, and improving actionable decision support. The company's key operating product segments are: Knowledge Networks, which generate maximum revenue, Diagnostics, Clinical Decision Support, and Coding and Data Quality Assurance. Geographically, it operates in Australia, its key revenue-generating market, Europe, and the Rest of the world.
28GF Score
Get the complete analysis for ASX:BMT
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:BMT has been successfully added to your 
